{"success":true,"data":{"pressRelease":{"id":"153790","rtpr_id":"nNFC3Wvqy5-20260928","ticker":"WELL","exchange":"TSX","all_tickers":["WELL"],"title":"WELL Health Subsidiary WELLSTAR Announces Conditional Approval for TSXV Listing and Files Filing Statement","author":"Newsfile Corp","published_at":"2026-09-28T10:00:14.614Z","article_body":"* WELLSTAR has received conditional approval from the TSX Venture Exchange as\na Tier 1 issuer, subject to satisfaction of the TSXV's customary listing\nconditions, and is expected to commence trading on or around October 1, 2026,\nunder the ticker symbol \"WSTR\".\nVancouver, British Columbia--(Newsfile Corp. - September 28, 2026) - WELL\nHealth Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) (\"WELL\"), a digital\nhealth company focused on positively impacting health outcomes by leveraging\ntechnology to empower healthcare practitioners and their patients globally, is\npleased to announce that, in connection with the previously announced\namalgamation (the \"Transaction\") of its subsidiary, WELLSTAR Technologies\nCorp. (\"WELLSTAR\") and 1587818 B.C. Ltd. (\"818\"), WELLSTAR and 818 have\nreceived conditional approval from the TSX Venture Exchange (\"TSXV\") and 818\nhas filed a filing statement dated September 25, 2026 (the \"Filing Statement\")\non 818's SEDAR+ profile at www.sedarplus.ca.\n\nThrough the Transaction, WELLSTAR and 818 will amalgamate to form an entity\nthat will be listed on the TSXV, the \"Resulting Issuer\", which will continue\non with the business of WELLSTAR.\n\nThe TSXV has conditionally approved the listing of the subordinate voting\nshares of the Resulting Issuer (the \"Resulting Issuer Subordinate Voting\nShares\") on the TSXV as a Tier 1 issuer under ticker symbol \"WSTR\". Final\napproval remains subject to satisfaction of the TSXV's customary listing\nconditions.\n\nThe Transaction is anticipated to close on September 29, 2026 with trading of\nthe Resulting Issuer Subordinate Voting Shares commencing two trading days\nlater, on or around October 1, 2026, under ticker symbol \"WSTR\".\n\nImmediately prior to completion of the Transaction, WELLSTAR will consolidate\nits subordinate voting shares and multiple voting shares on a six-for-one\nbasis (the \"Consolidation\"). Every six shares of each class will become one\nshare of the same class.\n\nFollowing the Consolidation and completion of the Transaction, the Resulting\nIssuer is expected to have a total of 77,223,308 shares issued and\noutstanding, comprising 35,603,308 Resulting Issuer Subordinate Voting Shares\nand 41,620,000 multiple voting shares (together, the \"Resulting Issuer\nShares\"). WELL Health will hold all of the Resulting Issuer's multiple voting\nshares. A total of 30,296,464 Resulting Issuer Subordinate Voting Shares will\nbe subject to voluntary lock-up arrangements.\n\nShareholders who hold their WELLSTAR or 818 subordinate voting shares in\nregistered form will receive their Resulting Issuer Subordinate Voting Shares\nin registered form. Shareholders who wish to hold these shares through a\nbrokerage account should contact their broker.\n\nWELL is also providing an update on WELLSTAR's previously announced treasury\noffering (the \"Treasury Offering\") and secondary offering by an existing\nWELLSTAR shareholder (the \"Secondary Offering\"). The net proceeds available to\nWELLSTAR from the Treasury Offering and the proceeds available to the existing\nshareholder from the Secondary Offering are being held in escrow pending\nsatisfaction of applicable release conditions, including the closing of the\nTransaction.\n\nThe subscription receipts issued in the Treasury Offering were priced at\nC$1.03 each, equivalent to a price of C$6.18 per post-Consolidation share.\n\nOnce the applicable release conditions are satisfied, each subscription\nreceipt issued in the Treasury Offering will entitle its holder to receive\none-sixth of a post-consolidation WELLSTAR subordinate voting share. These\nshares will then be exchanged on a one-for-one basis for Resulting Issuer\nSubordinate Voting Shares.\n\nFor further details on the Transaction, please refer to the Filing Statement,\nwhich has been posted on 818's profile on SEDAR+ at www.sedarplus.ca, as well\nas WELL's news releases dated July 7, 2026 and July 31, 2026. The Filing\nStatement provides detailed information about, among other things, the\nTransaction, WELLSTAR, 818 and the Resulting Issuer.\n\nWELL HEALTH TECHNOLOGIES CORP.\nPer: \"Hamed Shahbazi\"\nHamed Shahbazi\nChief Executive Officer, Chairman and Director\n\nAbout WELLSTAR Technologies Corp.\nWELLSTAR is a leading healthcare technology company dedicated to reshaping\nhealthcare through digital enablement. We provide a comprehensive, holistic\nsolution for healthcare providers across Canada, with over 40% of\npractitioners currently using our products and services. Our solutions serve\nprimary care and specialist physicians, health systems, and public-sector\norganizations through a complete suite of AI-enabled offerings, including\nbilling and practice management systems, electronic medical record (EMR)\nsystems, digital health applications, and digital health network solutions. As\na majority-owned subsidiary of WELL Health, WELLSTAR continues to drive\ninnovation and transformation in the Canadian healthcare landscape, reducing\nadministrative burden and empowering providers to deliver better patient\noutcomes through advanced technology solutions. Learn more at wellstar.health.\n\nAbout WELL Health Technologies Corp.\nWELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) is Canada's largest\noutpatient healthcare company and a leading provider of technology-enabled\nhealthcare solutions. WELL is building the infrastructure for a healthier\nCanada, where every patient gets better care, every provider is empowered by\nAI, and every piece of health data is protected. WELL owns and operates 275\nclinics in Canada, supporting more than 5 million annual patient visits.\nThrough its subsidiary WELLSTAR, WELL provides electronic medical records,\nAI-powered clinical tools, patient engagement platforms and IT management\nservices. WELL provides cybersecurity services through its CYBERWELL\nsubsidiary. WELL is publicly traded on the TSX under the symbol \"WELL\" and on\nthe OTC Exchange under the symbol \"WHTCF\". To learn more, please visit:\nwww.well.company.\n\nForward-Looking Statements\nThis news release contains \"forward-looking information\" within the meaning of\napplicable Canadian securities laws. Forward-looking information in this news\nrelease includes, without limitation, statements regarding: the completion and\nanticipated timing of the Transaction and the Consolidation; the intended\nlisting of the Resulting Issuer Subordinate Voting Shares on the TSXV and the\nanticipated commencement of trading; the satisfaction or waiver of the\nconditions required to complete the Transaction and obtain the listing; WELL\nHealth's shareholdings in the Resulting Issuer; WELLSTAR's growth strategy and\ncontinued growth, profitability, innovation and market position; and the\nanticipated benefits and impact of WELLSTAR's products, services and strategic\ninitiatives, including their ability to reduce administrative burden, empower\nhealthcare providers and contribute to improved patient outcomes.\n\nForward-Looking Information involve known and unknown risks, uncertainties and\nother factors that may cause future results, performance, or achievements to\nbe materially different from the estimated future results, performance or\nachievements expressed or implied by the Forward-Looking Information and the\nForward-Looking Information are not guarantees of future performance. WELL's\ncomments expressed or implied by such Forward-Looking Information are subject\nto a number of risks, uncertainties, and conditions, many of which are outside\nof WELL's control, and undue reliance should not be placed on such\ninformation. Forward-Looking Information are qualified in their entirety by\ninherent risks and uncertainties, including without limitation: satisfaction\nor waiver of all applicable conditions to the completion of the Transaction;\nWELLSTAR may incur costs even if the Transaction is not completed; liquidity\nrisk; leverage risk; and share price fluctuations; adverse market conditions\nand the ability to complete acquisitions; risks inherent in the primary\nhealthcare sector in general; continued patient and consumer demand for\nWELLSTAR's products and services; regulatory and legislative changes; that\nfuture results may vary from historical results; the inability to obtain any\nrequisite future financing on suitable terms; any inability to realize the\nexpected benefits and synergies from acquisitions; that market competition may\naffect the business, results and/or financial condition of WELLSTAR and other\nrisk factors identified in documents filed by WELL under its profile at\nwww.sedarplus.ca, including its most recent Annual Information Form. Except as\nrequired by securities laws, WELL and WELLSTAR do not assume any obligation to\nupdate or revise any Forward-Looking Information, whether as a result of new\ninformation, events or otherwise.\n\nNeither the TSX, the TSXV nor its Regulation Services Provider (as that term\nis defined in policies of the TSX or TSXV, respectively) accepts\nresponsibility for the adequacy or accuracy of this release.\n\nInvestors are cautioned that, except as disclosed in the Filing Statement, any\ninformation released or received with respect to the Transaction may not be\naccurate or complete and should not be relied upon.\n\nFor further information\nPardeep Sangha\nVice President, Investor Relations\ninvestor@well.company\n604-628-7266\n\nNot for distribution to United States news wire services or for dissemination\nin the United States.\n\n\nTo view the source version of this press release, please visit\nhttps://www.newsfilecorp.com/release/316274","article_body_html":"","raw_payload":{"data":{"id":"nNFC3Wvqy5-20260928","title":"WELL Health Subsidiary WELLSTAR Announces Conditional Approval for TSXV Listing and Files Filing Statement","author":"Newsfile Corp","ticker":"WELL","created":"2026-09-28T10:00:14.614Z","tickers":["WELL"],"exchange":"TSX","article_body":"* WELLSTAR has received conditional approval from the TSX Venture Exchange as\na Tier 1 issuer, subject to satisfaction of the TSXV's customary listing\nconditions, and is expected to commence trading on or around October 1, 2026,\nunder the ticker symbol \"WSTR\".\nVancouver, British Columbia--(Newsfile Corp. - September 28, 2026) - WELL\nHealth Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) (\"WELL\"), a digital\nhealth company focused on positively impacting health outcomes by leveraging\ntechnology to empower healthcare practitioners and their patients globally, is\npleased to announce that, in connection with the previously announced\namalgamation (the \"Transaction\") of its subsidiary, WELLSTAR Technologies\nCorp. (\"WELLSTAR\") and 1587818 B.C. Ltd. (\"818\"), WELLSTAR and 818 have\nreceived conditional approval from the TSX Venture Exchange (\"TSXV\") and 818\nhas filed a filing statement dated September 25, 2026 (the \"Filing Statement\")\non 818's SEDAR+ profile at www.sedarplus.ca.\n\nThrough the Transaction, WELLSTAR and 818 will amalgamate to form an entity\nthat will be listed on the TSXV, the \"Resulting Issuer\", which will continue\non with the business of WELLSTAR.\n\nThe TSXV has conditionally approved the listing of the subordinate voting\nshares of the Resulting Issuer (the \"Resulting Issuer Subordinate Voting\nShares\") on the TSXV as a Tier 1 issuer under ticker symbol \"WSTR\". Final\napproval remains subject to satisfaction of the TSXV's customary listing\nconditions.\n\nThe Transaction is anticipated to close on September 29, 2026 with trading of\nthe Resulting Issuer Subordinate Voting Shares commencing two trading days\nlater, on or around October 1, 2026, under ticker symbol \"WSTR\".\n\nImmediately prior to completion of the Transaction, WELLSTAR will consolidate\nits subordinate voting shares and multiple voting shares on a six-for-one\nbasis (the \"Consolidation\"). Every six shares of each class will become one\nshare of the same class.\n\nFollowing the Consolidation and completion of the Transaction, the Resulting\nIssuer is expected to have a total of 77,223,308 shares issued and\noutstanding, comprising 35,603,308 Resulting Issuer Subordinate Voting Shares\nand 41,620,000 multiple voting shares (together, the \"Resulting Issuer\nShares\"). WELL Health will hold all of the Resulting Issuer's multiple voting\nshares. A total of 30,296,464 Resulting Issuer Subordinate Voting Shares will\nbe subject to voluntary lock-up arrangements.\n\nShareholders who hold their WELLSTAR or 818 subordinate voting shares in\nregistered form will receive their Resulting Issuer Subordinate Voting Shares\nin registered form. Shareholders who wish to hold these shares through a\nbrokerage account should contact their broker.\n\nWELL is also providing an update on WELLSTAR's previously announced treasury\noffering (the \"Treasury Offering\") and secondary offering by an existing\nWELLSTAR shareholder (the \"Secondary Offering\"). The net proceeds available to\nWELLSTAR from the Treasury Offering and the proceeds available to the existing\nshareholder from the Secondary Offering are being held in escrow pending\nsatisfaction of applicable release conditions, including the closing of the\nTransaction.\n\nThe subscription receipts issued in the Treasury Offering were priced at\nC$1.03 each, equivalent to a price of C$6.18 per post-Consolidation share.\n\nOnce the applicable release conditions are satisfied, each subscription\nreceipt issued in the Treasury Offering will entitle its holder to receive\none-sixth of a post-consolidation WELLSTAR subordinate voting share. These\nshares will then be exchanged on a one-for-one basis for Resulting Issuer\nSubordinate Voting Shares.\n\nFor further details on the Transaction, please refer to the Filing Statement,\nwhich has been posted on 818's profile on SEDAR+ at www.sedarplus.ca, as well\nas WELL's news releases dated July 7, 2026 and July 31, 2026. The Filing\nStatement provides detailed information about, among other things, the\nTransaction, WELLSTAR, 818 and the Resulting Issuer.\n\nWELL HEALTH TECHNOLOGIES CORP.\nPer: \"Hamed Shahbazi\"\nHamed Shahbazi\nChief Executive Officer, Chairman and Director\n\nAbout WELLSTAR Technologies Corp.\nWELLSTAR is a leading healthcare technology company dedicated to reshaping\nhealthcare through digital enablement. We provide a comprehensive, holistic\nsolution for healthcare providers across Canada, with over 40% of\npractitioners currently using our products and services. Our solutions serve\nprimary care and specialist physicians, health systems, and public-sector\norganizations through a complete suite of AI-enabled offerings, including\nbilling and practice management systems, electronic medical record (EMR)\nsystems, digital health applications, and digital health network solutions. As\na majority-owned subsidiary of WELL Health, WELLSTAR continues to drive\ninnovation and transformation in the Canadian healthcare landscape, reducing\nadministrative burden and empowering providers to deliver better patient\noutcomes through advanced technology solutions. Learn more at wellstar.health.\n\nAbout WELL Health Technologies Corp.\nWELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) is Canada's largest\noutpatient healthcare company and a leading provider of technology-enabled\nhealthcare solutions. WELL is building the infrastructure for a healthier\nCanada, where every patient gets better care, every provider is empowered by\nAI, and every piece of health data is protected. WELL owns and operates 275\nclinics in Canada, supporting more than 5 million annual patient visits.\nThrough its subsidiary WELLSTAR, WELL provides electronic medical records,\nAI-powered clinical tools, patient engagement platforms and IT management\nservices. WELL provides cybersecurity services through its CYBERWELL\nsubsidiary. WELL is publicly traded on the TSX under the symbol \"WELL\" and on\nthe OTC Exchange under the symbol \"WHTCF\". To learn more, please visit:\nwww.well.company.\n\nForward-Looking Statements\nThis news release contains \"forward-looking information\" within the meaning of\napplicable Canadian securities laws. Forward-looking information in this news\nrelease includes, without limitation, statements regarding: the completion and\nanticipated timing of the Transaction and the Consolidation; the intended\nlisting of the Resulting Issuer Subordinate Voting Shares on the TSXV and the\nanticipated commencement of trading; the satisfaction or waiver of the\nconditions required to complete the Transaction and obtain the listing; WELL\nHealth's shareholdings in the Resulting Issuer; WELLSTAR's growth strategy and\ncontinued growth, profitability, innovation and market position; and the\nanticipated benefits and impact of WELLSTAR's products, services and strategic\ninitiatives, including their ability to reduce administrative burden, empower\nhealthcare providers and contribute to improved patient outcomes.\n\nForward-Looking Information involve known and unknown risks, uncertainties and\nother factors that may cause future results, performance, or achievements to\nbe materially different from the estimated future results, performance or\nachievements expressed or implied by the Forward-Looking Information and the\nForward-Looking Information are not guarantees of future performance. WELL's\ncomments expressed or implied by such Forward-Looking Information are subject\nto a number of risks, uncertainties, and conditions, many of which are outside\nof WELL's control, and undue reliance should not be placed on such\ninformation. Forward-Looking Information are qualified in their entirety by\ninherent risks and uncertainties, including without limitation: satisfaction\nor waiver of all applicable conditions to the completion of the Transaction;\nWELLSTAR may incur costs even if the Transaction is not completed; liquidity\nrisk; leverage risk; and share price fluctuations; adverse market conditions\nand the ability to complete acquisitions; risks inherent in the primary\nhealthcare sector in general; continued patient and consumer demand for\nWELLSTAR's products and services; regulatory and legislative changes; that\nfuture results may vary from historical results; the inability to obtain any\nrequisite future financing on suitable terms; any inability to realize the\nexpected benefits and synergies from acquisitions; that market competition may\naffect the business, results and/or financial condition of WELLSTAR and other\nrisk factors identified in documents filed by WELL under its profile at\nwww.sedarplus.ca, including its most recent Annual Information Form. Except as\nrequired by securities laws, WELL and WELLSTAR do not assume any obligation to\nupdate or revise any Forward-Looking Information, whether as a result of new\ninformation, events or otherwise.\n\nNeither the TSX, the TSXV nor its Regulation Services Provider (as that term\nis defined in policies of the TSX or TSXV, respectively) accepts\nresponsibility for the adequacy or accuracy of this release.\n\nInvestors are cautioned that, except as disclosed in the Filing Statement, any\ninformation released or received with respect to the Transaction may not be\naccurate or complete and should not be relied upon.\n\nFor further information\nPardeep Sangha\nVice President, Investor Relations\ninvestor@well.company\n604-628-7266\n\nNot for distribution to United States news wire services or for dissemination\nin the United States.\n\n\nTo view the source version of this press release, please visit\nhttps://www.newsfilecorp.com/release/316274"},"type":"article","timestamp":"2026-09-28T10:00:14.679578838Z","server_sent_at_ms":1790589614679},"received_at":"2026-09-28T10:00:14.748Z","source_url":"https://www.newsfilecorp.com/release/316274"},"analysis":{"id":"142577","press_release_id":"153790","analysis_json":{"industry":{"label":"Health Care Providers & Services","sector":"Health Care"},"redFlags":["Listing remains subject to satisfaction of customary TSXV conditions -- not yet final","Offering proceeds held in escrow pending release conditions"],"eventType":"other","narrative":"WELLSTAR Technologies, WELL Health's majority-owned subsidiary, received conditional TSXV approval to list as a Tier 1 issuer under ticker WSTR, with trading expected around October 1, 2026.\n\nWELLSTAR and 818 will amalgamate on September 29, 2026, following a six-for-one share consolidation; the Resulting Issuer will have 77,223,308 shares outstanding, with WELL holding all 41.62 million multiple voting shares.\n\nProceeds from the Treasury and Secondary Offerings remain in escrow pending closing, and the C$1.03 subscription receipts equate to C$6.18 per post-Consolidation share.","sentiment":"bullish","agentHooks":{"shouldPost":true,"suggestedAngle":"WELLSTAR one step from TSXV Tier 1 trading under WSTR -- watch for the value-unlocking read-through to WELL Health shares at close."},"keyFigures":{"customDimensions":{"consolidation_ratio":"six-for-one","annual_patient_visits":"5 million","multiple_voting_shares":41620000,"treasury_offering_price":"C$1.03 per subscription receipt (C$6.18 per post-Consolidation share)","clinics_operated_by_well":275,"practitioner_penetration":"40%","subordinate_voting_shares":35603308,"locked_up_subordinate_voting_shares":30296464,"resulting_issuer_shares_outstanding":77223308}},"namedEntities":{"people":[{"name":"Hamed Shahbazi","role":"CEO, Chairman and Director of WELL Health"},{"name":"Pardeep Sangha","role":"Vice President, Investor Relations"}],"products":["WELLSTAR EMR","CYBERWELL"],"companies":[{"name":"WELL Health Technologies Corp.","ticker":"WELL","relationship":"filer / parent company"},{"name":"WELLSTAR Technologies Corp.","relationship":"subsidiary being spun out via amalgamation"},{"name":"1587818 B.C. Ltd. (818)","relationship":"amalgamation partner / listing vehicle"},{"name":"TSX Venture Exchange","relationship":"exchange granting conditional listing approval"}],"dollarAmounts":[{"amount":"C$1.03","context":"price per subscription receipt in WELLSTAR Treasury Offering"},{"amount":"C$6.18","context":"equivalent price per post-Consolidation share"}]},"materialImpact":{"score":2,"reasoning":"Conditional TSXV approval is a procedural milestone in the previously announced WELLSTAR amalgamation/spin-out; closing is expected Sept 29 with trading ~Oct 1. No new financial results or capital raised disclosed, but it advances a structural value-unlocking event for WELL shareholders."},"tickerRelevance":{"others":[{"ticker":"WHTCF","relevance":"OTCQX listing of the filer"},{"ticker":"WSTR","relevance":"ticker of the Resulting Issuer (WELLSTAR amalgamated entity) to be listed on TSXV"}],"primary":"WELL"},"globalImportance":28,"audienceRelevance":25,"eventTypeSecondary":["m_and_a"],"importanceComponents":{"tickerTier":"mid-cap TSX-listed","eventGravity":"subsidiary listing milestone","sectorWeight":"digital health","issuerAuthored":true}},"event_type":"other","event_type_secondary":["m_and_a"],"sentiment":"bullish","material_impact_score":2,"narrative":"WELLSTAR Technologies, WELL Health's majority-owned subsidiary, received conditional TSXV approval to list as a Tier 1 issuer under ticker WSTR, with trading expected around October 1, 2026.\n\nWELLSTAR and 818 will amalgamate on September 29, 2026, following a six-for-one share consolidation; the Resulting Issuer will have 77,223,308 shares outstanding, with WELL holding all 41.62 million multiple voting shares.\n\nProceeds from the Treasury and Secondary Offerings remain in escrow pending closing, and the C$1.03 subscription receipts equate to C$6.18 per post-Consolidation share.","key_figures":{"customDimensions":{"consolidation_ratio":"six-for-one","annual_patient_visits":"5 million","multiple_voting_shares":41620000,"treasury_offering_price":"C$1.03 per subscription receipt (C$6.18 per post-Consolidation share)","clinics_operated_by_well":275,"practitioner_penetration":"40%","subordinate_voting_shares":35603308,"locked_up_subordinate_voting_shares":30296464,"resulting_issuer_shares_outstanding":77223308}},"named_entities":{"people":[{"name":"Hamed Shahbazi","role":"CEO, Chairman and Director of WELL Health"},{"name":"Pardeep Sangha","role":"Vice President, Investor Relations"}],"products":["WELLSTAR EMR","CYBERWELL"],"companies":[{"name":"WELL Health Technologies Corp.","ticker":"WELL","relationship":"filer / parent company"},{"name":"WELLSTAR Technologies Corp.","relationship":"subsidiary being spun out via amalgamation"},{"name":"1587818 B.C. Ltd. (818)","relationship":"amalgamation partner / listing vehicle"},{"name":"TSX Venture Exchange","relationship":"exchange granting conditional listing approval"}],"dollarAmounts":[{"amount":"C$1.03","context":"price per subscription receipt in WELLSTAR Treasury Offering"},{"amount":"C$6.18","context":"equivalent price per post-Consolidation share"}]},"model_name":"glm-5.3-flashx","prompt_hash":"sha256:727b4b9429a443af","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-09-28T10:00:22.941Z","global_importance":28,"audience_relevance":25,"importance_components":{"tickerTier":"mid-cap TSX-listed","eventGravity":"subsidiary listing milestone","sectorWeight":"digital health","issuerAuthored":true}},"durationMs":8176,"modelName":"glm-5.3-flashx"}}